Using insulin syringes with half-unit markings improves accuracy for small volumes
Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder
In actinically damaged skin, slowly growing (non-invasive) melanoma (in situ melanoma)
Understanding the full range of ghk-cu benefits alongside core nad+ benefits makes this clearer
Nigdelioglu R, Hamanaka RB, Meliton AY, OLeary E, Witt LJ, Cho T, et al
Effect size calculations (Cohens d) and power analysis were conducted using G*Power 3.1 software ( with statistical significance set at p 0.05)